Brief: Bavarian Nordic's Chikungunya Vaccine Submitted For Regulatory Approval In Brazil
13/07/2026 14:01
BRIEF-Bavarian Nordic's Chikungunya Vaccine Submitted For Regulatory Approval In Brazil July 13 (Reuters) - Bavarian Nordic A/S BAVA.CO:
CHIKUNGUNYA VACCINE SUBMITTED FOR REGULATORY APPROVAL IN BRAZIL
Source text: ID:nGNE3Qw9QJ
Further company coverage: BAVA.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bavarian Nordic A/S
See all newsBrief: Bavarian Nordic Completes First Tranche Of Share Buy-Back Program
Bavarian Nordic gets four-year contract for mpox and smallpox vaccine from UK government
Brief: Bavarian Nordic Awarded Multi-Year Vaccine Contract By UK Government
Bavarian Nordic donates 75,000 mpox vaccine doses to global emergency stockpile
Brief: Bavarian Nordic Donates To Global Mpox Emergency Stockpile